Simple dialysis change could save thousands of lives, major trial hints

NCT ID NCT04079582

First seen May 04, 2026 · Last updated May 13, 2026 · Updated 1 time

Summary

This study looks at whether raising the magnesium level in the fluid used during dialysis can help people with end-stage kidney disease live longer and avoid heart-related hospital stays. Many dialysis patients have low magnesium, which is linked to higher risks of death, heart issues, and muscle cramps. The trial involves 25,000 patients across many dialysis centers, comparing standard magnesium levels to a higher one, to see if this simple, low-cost change improves health outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMODIALYSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • London Health Sciences Centre

    London, Ontario, N6A5W9, Canada

Conditions

Explore the condition pages connected to this study.